EpCAM-CAR T-cells are now being tested in a number of clinical trials for several cancers such as breast cancer, HCC, pancreatic cancer, and GC, though their effectiveness has yet to be demonstrated (NCT02915445 and NCT05028933). This evidence concerns the gene EPCAM and cancer.